Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.70
+0.04 (0.52%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $52.22 million as of July 10, 2026. Its market cap has decreased by -70.42% in one year.
Market Cap
52.22M
Enterprise Value
62.84M
1-Year Change
-70.42%
Ranking
Category
Stock Price
$7.70
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $52.22M, a decrease of -97.92%. That is a compound annual growth rate of -51.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 52.22M | -30.00% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 57.00M |
| Veraxa Biotech AG | 55.48M |
| MiNK Therapeutics | 55.05M |
| Xilio Therapeutics | 54.44M |
| Boundless Bio | 54.13M |
| Mereo BioPharma Group | 53.47M |
| aTyr Pharma | 53.38M |
| Immutep | 52.28M |